Decreased susceptibility to chlorhexidine and distribution of qacA/B genes among coagulase-negative Staphylococcus clinical samples

BMC Infectious Diseases
Bruna Costa Moura do ValeMaria Celeste Nunes de Melo

Abstract

Healthcare-associated infection (HAI) is a major public health problem. As a form of prevention and control, preparations of chlorhexidine are used extensively; however, the reduction of susceptibility to chlorhexidine has been reported. The aim of this study was to investigate the susceptibility to chlorhexidine and the distribution of the qacA/B genes in 211 clinical isolates of coagulase-negative Staphylococci (CoNS). CoNS were identified by conventional biochemical tests. Antimicrobial susceptibility was tested by disk-diffusion. Minimum inhibitory concentration (MIC) of chlorhexidine was determined by agar dilution test; detection of the qacA/B and mecA genes were evaluated by PCR. The most frequently isolated species were S. epidermidis, S. hominis hominis, S. auricularis, and S. haemolyticus, respectively. The strains presented a multidrug resistance profile of 87%, including methicillin resistance. Reduced susceptibility to chlorhexidine was observed in 31%. The qacA/B genes were detected in samples resistant (32/32) and susceptible (17/32) to chlorhexidine. The vast majority (94%) of the samples with reduced susceptibility to chlorhexidine were multidrug resistant. Our results show that qacA/B genes are not restricted ...Continue Reading

References

Aug 30, 2001·Journal of Clinical Microbiology·K J EdwardsN A Saunders
Apr 9, 2005·Journal of Clinical Microbiology·Eliete A M FrigattoAna C Gales
Jul 4, 2007·Memórias do Instituto Oswaldo Cruz·Neide H Tokumaru MiyazakiMaria Helena S Villas Bôas
Feb 17, 2009·Diagnostic Microbiology and Infectious Disease·Wang-Huei ShengShan-Chwen Chang
Apr 13, 2010·The Journal of Hospital Infection·C F TeixeiraM H S Villas Boas
Jul 27, 2012·The Journal of Antimicrobial Chemotherapy·Carolyne HornerMark Wilcox
Apr 10, 2013·The Open Microbiology Journal·Sofia Santos CostaIsabel Couto
Mar 19, 2014·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·Gustaf PragBo Söderquist
May 21, 2014·Antimicrobial Agents and Chemotherapy·Carey D SchlettMichael W Ellis
Apr 18, 2015·European Journal of Microbiology & Immunology·Trudy M WassenaarHanne Ingmer
Nov 11, 2015·Antimicrobial Agents and Chemotherapy·Teresa ConceiçãoMarta Aires-de-Sousa
Nov 24, 2016·International Journal of Medical Microbiology : IJMM·Chimène NanoukonGilles Prévost

❮ Previous
Next ❯

Methods Mentioned

BETA
PCR
electrophoresis

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.